Improve Research Reproducibility A Bio-protocol resource
Concise Method
tooltip

Xenogen imaging

MV Maud Vandereyken
SJ Sophie Jacques
EO Eva Van Overmeire
MA Mathieu Amand
NR Natacha Rocks
CD Céline Delierneux
PS Pratibha Singh
MS Maneesh Singh
CG Camille Ghuysen
CW Caroline Wathieu
TZ Tinatin Zurashvili
NS Nor Eddine Sounni
MM Michel Moutschen
CG Christine Gilles
CO Cécile Oury
DC Didier Cataldo
JG Jo A. Van Ginderachter
SR Souad Rahmouni
request Request a Protocol
ask Ask a question
Favorite

The LLC or B16 tumour progression was monitored using Imaging System Xenogen IVIS 200 (Advanced Molecular Vision, Caliper Lifesciences, Waltham, MA, United States). 100 μl of luciferin potassium salt (30mg/ml) was intraperitoneally injected in tumour bearing DUSP3+/+ and DUSP3-/- mice. After 12 minutes, the photons emitted by the luciferase activity were detected. The bioluminescence was quantified using the Living Image Software (Caliper Life Sciences, Waltham, MA, United States) and by delimitation of region of interest (ROI) around the lungs.

Copyright and License information:  ©2017 Vandereyken et al
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

0/150

tip Tips for asking effective questions

+ Description

Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.

post Post a Question
0 Q&A